mTOR signaling pathway genes effect in COVID-19 infection
Abstract
Coronavirus disease 2019 (Covid-19) is an infectious disease that causes severe acute respiratory illness caused by coronavirus 2 (SARS-CoV-2). SARS-CoV-2 uses host-specific metabolic pathways, including mTOR. The mTOR pathway is hyperactive in viral respiratory tract infections and contributes positively to viral replication. 100 samples were evaluated, 50 patients (Female=23, Male=27), and 50 controls (Female=29, Male=21). The patients were individuals who were COVID-19 positive. We detected expression changes of 5 genes in mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) (MLST8, mTOR, RPTOR, MAPKAP1 and RICTOR). Serum samples were obtained from all patients. The expression changes of mTORC1 and mTORC2 Complex genes were evaluated with Real-time PCR method. Receiver operating curve (ROC) analysis was performed to define the diagnostic power of these genes. Expression changes of five genes in the mTORC1 and mTORC2 complex were statistically significant (p =0.001) and upregulated in serum. The area under the ROC Curve values indicating the diagnostic power of genes were 0.948, 0.771, 0.851, 0.798, and 0.805, respectively. These genes may be candidate for treatment targets. The high discriminative power of these genes in patients from controls indicates their diagnostic potential in serum samples.
Keywords
COVID-19, SARS-CoV-2, mTOR complex 1 (mTORC1), mTOR complex 2 (mTORC2)
Supporting Institution
Malatya Turgut Ozal University
Project Number
Project No:2021/7
Ethical Statement
This study has been approved by the clinical research ethics committee of Malatya Turgut Ozal University (2021/27).
References
- Referans1 de Groot, R.J.B., S.C.; Baric, R.; Enjuanes, L.; Gorbalenya, A.E.; Holmes, K.V.; Perlman, S.; Poon, L.; Rottier, P.J.M.; Talbot, P.J.; Woo, P.C.Y.; Ziebuhr, J.; King, A.M.Q.; Adams, M.J.; Carstens, E.B.; Lefkowitz, E.J, Virus Taxonomy, Ninth Report of the International Committee on Taxonomy of Viruses. 2011: p. 806 - 828 e17.
- Referans2 Troyano-Hernáez, P., R. Reinosa, and Á. Holguín, Evolution of SARS-CoV-2 envelope, membrane, nucleocapsid, and spike structural proteins from the beginning of the pandemic to September 2020: a global and regional approach by epidemiological week. Viruses, 2021. 13(2): p. 243.
- Referans3 Jackson, C.B., et al., Mechanisms of SARS-CoV-2 entry into cells. Nature reviews Molecular cell biology, 2022. 23(1): p. 3-20.
- Referans4 Zhang, J., et al., Structure of SARS-CoV-2 spike protein. Current Opinion in Virology, 2021. 50: p. 173-182.
- Referans5 Pal, M., et al., Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus, 2020. 12(3).
- Referans6 Sharma, A., et al., Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. International journal of antimicrobial agents, 2020. 56(2): p. 106054.
- Referans7 Babyn, P.S., et al., Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatric radiology, 2004. 34(1): p. 47-58.
- Referans8 Saxton, R.A. and D.M. Sabatini, mTOR signaling in growth, metabolism, and disease. Cell, 2017. 168(6): p. 960-976.
- Referans9 Mazewski, C., et al., Type I interferon (IFN)-regulated activation of canonical and non-canonical signaling pathways. Frontiers in immunology, 2020. 11: p. 606456.
- Referans10 Fattahi, S., et al., PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy. Immunologic Research, 2022: p. 1-7.